Literature DB >> 12798246

MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination.

Susana Vázquez1, Odaysa Valdés, Maritza Pupo, Iselys Delgado, Mayling Alvarez, Jose Luis Pelegrino, Maria G Guzmán.   

Abstract

The IgM antibody capture ELISA (MAC-ELISA) and ELISA inhibition methods for the detection of antibodies against dengue virus were modified to detect antibodies against yellow fever virus. Tests were carried out in 21 persons vaccinated with 17D and compared with the Plaque reduction neutralizing test. Of 17 naive subjects vaccinated, 16 (94%) seroconverted using the MAC-ELISA test and 14 (82%) seroconverted (or >/=fourfold titer increase) in the ELISA inhibition method. Cross-reactivity was evaluated by both tests and resulted in a high specificity to IgM antibodies against yellow fever, when all the samples from vaccinated individuals were negative by MAC-ELISA using dengue antigen. However, 10.7% of the positive dengue sera from the Santiago de Cuba epidemic cross-reacted by MAC-ELISA using yellow fever antigen. ELISA inhibition method showed high cross-reactivity when the 21 sera pairs were worked with yellow fever and dengue antigens. The MAC-ELISA and ELISA inhibition methods have become indispensable tools in our laboratory in order to maintain a surveillance system for dengue and dengue hemorrhagic fever. They are relatively rapid, simple, and they do not require sophisticated equipment. Both MAC-ELISA and ELISA inhibition methods for yellow fever could be useful for diagnosis, surveillance and yellow fever vaccine evaluation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798246     DOI: 10.1016/s0166-0934(03)00128-9

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  16 in total

1.  Diagnosis of dengue virus infection by the visual and simple AuBioDOT immunoglobulin M capture system.

Authors:  Susana Vázquez; Gilda Lemos; Maritza Pupo; Oscar Ganzón; Daniel Palenzuela; Adriana Indart; María G Guzmán
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  STATEMENT FOR TRAVELLERS AND YELLOW FEVER: An Advisory Committee Statement (ACS) Committee to Advise on Tropical Medicine and Travel (CATMAT).

Authors:  This Statement Was Prepared By P Charlebois
Journal:  Can Commun Dis Rep       Date:  2013-03-05

3.  Statement for Travellers and Yellow Fever: Committee to Advise on Tropical Medicine and Travel.

Authors:  P Charlebois
Journal:  Can Commun Dis Rep       Date:  2010-10-02

Review 4.  Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

Authors:  Eduardo Gotuzzo; Sergio Yactayo; Erika Córdova
Journal:  Am J Trop Med Hyg       Date:  2013-09       Impact factor: 2.345

Review 5.  Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat.

Authors:  Jesse J Waggoner; Alejandra Rojas; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

6.  Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism.

Authors:  Gissel García; Beatriz Sierra; Ana B Pérez; Eglys Aguirre; Ileana Rosado; Narjara Gonzalez; Alienys Izquierdo; Maritza Pupo; Didye Ruiz Danay Díaz; Lizet Sánchez; Beatriz Marcheco; Kenji Hirayama; María G Guzmán
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

7.  Monoclonal antibody to dengue capsid protein: its application in dengue studies.

Authors:  Y Vazquez; Maritza Pupo-Antúnez; S V Vazquez; V Capó; G Torres; Y Caballero; A Sánchez; D Limonta; M Alvarez; M G Guzmán
Journal:  MAbs       Date:  2009-03-21       Impact factor: 5.857

8.  Yellow fever virus envelope protein expressed in insect cells is capable of syncytium formation in lepidopteran cells and could be used for immunodetection of YFV in human sera.

Authors:  Maria C E S Barros; Tatiane G C M Galasso; Antônio J M Chaib; Nicolas Degallier; Tatsuya Nagata; Bergmann M Ribeiro
Journal:  Virol J       Date:  2011-05-27       Impact factor: 4.099

9.  Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil.

Authors:  Andréa Barbosa de Melo; Maria da Paz C da Silva; Maria Cecília F Magalhães; Laura Helena Vega Gonzales Gil; Eduardo M Freese de Carvalho; Ulisses M Braga-Neto; Giovani Rota Bertani; Ernesto T A Marques; Marli Tenório Cordeiro
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

10.  Evaluation of commercially available anti-dengue virus immunoglobulin M tests.

Authors:  Elizabeth A Hunsperger; Sutee Yoksan; Philippe Buchy; Vinh Chau Nguyen; Shamala D Sekaran; Delia A Enria; Jose L Pelegrino; Susana Vázquez; Harvey Artsob; Michael Drebot; Duane J Gubler; Scott B Halstead; María G Guzmán; Harold S Margolis; Carl-Michael Nathanson; Nidia R Rizzo Lic; Kovi E Bessoff; Srisakul Kliks; Rosanna W Peeling
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.